USA - engelsk - NLM (National Library of Medicine)

elanco us inc. - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime 1 mg in 1 ml - milbemite otic solution is indicated for treatment of ear mite (otodectes cynotis ) infestations in cats and kittens four weeks of age and older. effectiveness is maintained throughout the life cycle of the ear mite.

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) -

USA - engelsk - NLM (National Library of Medicine)

darmerica, llc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) -

USA - engelsk - NLM (National Library of Medicine)

virbac ah, inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt), lufenuron (unii: 1r754m4918) (lufenuron - unii:1r754m4918) - milbemycin oxime 11.5 mg - sentinel flavor tabs are indicated for use in dogs and puppies, four weeks of age and older, and two pounds body weight or greater. sentinel flavor tabs are also indicated for the prevention of heartworm disease caused by dirofilaria immitis for the prevention and control of flea populations, the control of adult ancylostoma caninum (hookworm), and the removal and control of adult toxocara canis and toxascaris leonina (roundworm) and trichuris vulpis (whipworm) infections. lufenuron controls flea populations by preventing the development of flea eggs and does not kill adult fleas. concurrent use of an adulticide product may be necessary for adequate control of adult fleas. without concurrent use of an adulticide, adequate flea control may not be achieved in dogs that have repeated exposure to flea infested animals or environments.

USA - engelsk - NLM (National Library of Medicine)

elanco us inc, - spinosad (unii: xpa88eap6v) (spinosad - unii:xpa88eap6v), milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - spinosad 140 mg - trifexis is indicated for the prevention of heartworm disease (dirofilaria immitis ). trifexis kills fleas and is indicated for the prevention and treatment of flea infestations (ctenocephalides felis ), and the treatment and control of adult hookworm (ancylostoma caninum ), adult roundworm (toxocara canis and toxascaris leonina ) and adult whipworm (trichuris vulpis ) infections in dogs and puppies 8 weeks of age or older and 5 pounds of body weight or greater. there are no known contraindications to the use of trifexis.

USA - engelsk - NLM (National Library of Medicine)

virbac ah, inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt), lufenuron (unii: 1r754m4918) (lufenuron - unii:1r754m4918), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - milbemycin oxime 5.75 mg - important directions for use: - to ensure adequate absorption, always administer sentinel® spectrum® (milbemycin oxime/lufenuron/praziquantel) to dogs immediately after or in conjunction with a normal meal. - sentinel spectrum controls flea populations by breaking the flea lifecycle in both the egg and larval stages. - it is important to treat all dogs and cats in the household for fleas. - sentinel spectrum must be administered monthly for at least 6 months after exposure to mosquitoes.

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime 495 g in 500 g

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - milbemycin oxime 49.5 g in 50 g

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) -

USA - engelsk - NLM (National Library of Medicine)

kalchem international inc - milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) -